Home | News | Find a Doctor | Ask a Question | Free

Aderans Research Expands Clinical Studies


#1

Thanks to @Dogster who found this new Aderans press release and posted it - IMHO a little bit too hidden - in another (related) topic …


Source: http://www.prweb.com/releases/hair/regeneration/prweb3954514.htm

Aderans Research Expands Clinical Studies

Aderans Research Institute Inc. (ARI) said today it has expanded its clinical trials on hair regeneration by an additional seven cities in the United States.

Atlanta, GA (PRWEB) May 4, 2010 – Aderans Research Institute Inc. (ARI) said today it has expanded its clinical trials on hair regeneration by an additional seven cities in the United States. Las Vegas, NV; Los Angeles, CA; and New Hyde Park, NY, have been added through clinical site company Impact Clinical Trials. Tucson, AZ; St. Louis, MO; Birmingham, AL; and St. Petersburg, FL, have been added through clinical site company Radiant Research.

Collectively, the Radiant and Impact sites will add around 80 new subjects to the study. Combined with at least twenty new additions at a site hosted by TKL Research, the second phase of ARI’s clinical study will surpass 200 subjects in total, a remarkable number of participants for a Phase 2 trial.

“The expansion of our study reflects not only the significance of the investment made by Aderans Co. Ltd of Japan, but also our confidence that we’re getting closer to a commercial viable solution to the problems of hair loss,” said Vern Liebmann, Vice President, Operations.

Added ARI Executive Vice President Ken Washenik M.D., Ph.D., “We’ve received some encouraging results from our initial Phase 2 studies and we’re eager to expand the trial, add new protocols, and refine our knowledge of the hair multiplication and regeneration process.”

Kurt Stenn M.D., Vice President of Research and Chief Scientific Officer, commented, “It is gratifying to see our research being steadily confirmed in our clinical work.”

Phase 2 launched in November of 2008. Phase 1 of ARI’s clinical study began in September of 2006 and concluded in February of 2008.

About Aderans Research

Aderans Research is a pioneer in the research and development of safe, effective cell engineered products for hair regeneration. With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd., the world’s largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.

More information on ARI’s study outcomes will be released as studies unfold. To see ARI’s latest clinical updates, please visit http://www.aderansresearch.com/ari_clinicupdates.html

Additional information on ARI can be found at www.aderansresearch.com.

Learn more about Aderans Co., Ltd. At http://www.aderans.co.jp/e/company/


By the way …

Phase 2 launched in November of 2008. Phase 1 of ARI’s clinical study began in September of 2006 and concluded in February of 2008.

This is the reason, why I often mention “Do not believe in every press release …!”

Phase 2 launched - as most of you guys know - in April 2009!


#2

» Thanks to @Dogster who found this new Aderans press release and
» posted it - IMHO a little bit too hidden - in another topic …
»
» -----------------------
» Source: http://www.prweb.com/releases/hair/regeneration/prweb3954514.htm
»
» Aderans Research Expands Clinical Studies
»
» Aderans Research Institute Inc. (ARI) said today it has expanded its
» clinical trials on hair regeneration by an additional seven cities in the
» United States.
»
» Atlanta, GA (PRWEB) May 4, 2010 – Aderans Research Institute Inc.
» (ARI) said today it has expanded its clinical trials on hair regeneration
» by an additional seven cities in the United States. Las Vegas, NV; Los
» Angeles, CA; and New Hyde Park, NY, have been added through clinical site
» company Impact Clinical Trials. Tucson, AZ; St. Louis, MO; Birmingham, AL;
» and St. Petersburg, FL, have been added through clinical site company
» Radiant Research.
»
» Collectively, the Radiant and Impact sites will add around 80 new subjects
» to the study. Combined with at least twenty new additions at a site hosted
» by TKL Research, the second phase of ARI’s clinical study will surpass 200
» subjects in total, a remarkable number of participants for a Phase 2 trial.
»
»
» “The expansion of our study reflects not only the significance of the
» investment made by Aderans Co. Ltd of Japan, but also our confidence that
» we’re getting closer to a commercial viable solution to the problems of
» hair loss,” said Vern Liebmann, Vice President, Operations.
»
» Added ARI Executive Vice President Ken Washenik M.D., Ph.D., “We’ve
» received some encouraging results from our initial Phase 2 studies and
» we’re eager to expand the trial, add new protocols, and refine our
» knowledge of the hair multiplication and regeneration process.”
»
» Kurt Stenn M.D., Vice President of Research and Chief Scientific Officer,
» commented, “It is gratifying to see our research being steadily confirmed
» in our clinical work.”
»
» Phase 2 launched in November of 2008. Phase 1 of ARI’s
» clinical study began in September of 2006 and concluded in February of
» 2008.

»
» About Aderans Research
»
» Aderans Research is a pioneer in the research and development of safe,
» effective cell engineered products for hair regeneration. With offices in
» Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of
» Aderans Company, Ltd., the world’s largest wig manufacturer, and an
» affiliate of Bosley, a global leader in medical hair restoration.
»
» More information on ARI’s study outcomes will be released as studies
» unfold. To see ARI’s latest clinical updates, please visit
» http://www.aderansresearch.com/ari_clinicupdates.html
»
» Additional information on ARI can be found at www.aderansresearch.com.
»
» Learn more about Aderans Co., Ltd. At http://www.aderans.co.jp/e/company/
»
» ###
» --------------------------------
»
» By the way …
» ------------
» Phase 2 launched in November of 2008. Phase 1 of ARI’s
» clinical study began in September of 2006 and concluded in February of
» 2008.

» ------------
»
» This is the reason, why I often mention “Do not believe in every press
» release …!”

»
» Phase 2 launched - as most of you guys know - in April
» 2009
!

I am confused by this post why would they lie about when they were doing Phase 2? That doesn’t make any sense to me…


#3

» I am confused by this post why would they lie about when they were doing
» Phase 2? That doesn’t make any sense to me…

But it makes absolutely sense to me - and I already mentioned several times the reason for that … :wink:


#4

They didn’t lie. Phase 2 starts at recruitment. They started recruiting during 2008.


#5

» They didn’t lie. Phase 2 starts at recruitment. They started recruiting
» during 2008.

And what can you read in THIS press release???

Atlanta, GA (PRWEB) April 27, 2009 – Aderans Research Institute Inc. (ARI) announced today it has launched Phase 2 of its clinical study on cell-based hair regeneration for men and women. Structured around the findings of the recently completed Phase 1 of the study, this second phase will continue to evaluate the impact of its novel cell treatment process on pattern hair loss, also known as androgenetic alopecia.


#6

» » They didn’t lie. Phase 2 starts at recruitment. They started recruiting
» » during 2008.
»
» And what can you read in THIS press release???
» ----------------
» http://www.prweb.com/releases/pattern_hair_loss_study/hair_restoration_research/prweb2358404.htm
»
»
» Atlanta, GA (PRWEB) April 27, 2009 – Aderans Research Institute
» Inc. (ARI) announced today it has launched Phase 2 of its clinical
» study
on cell-based hair regeneration for men and women. Structured
» around the findings of the recently completed Phase 1 of the study,
» this second phase will continue to evaluate the impact of its novel cell
» treatment process on pattern hair loss, also known as androgenetic
» alopecia.
» ------------------

Thanks Shooter! The last thing I need is to be misinformed. I do hope the hurry up with releasing the results for this thing. I also realize though it might be a little longer now that they expanded the whole P2 trails.


#7

» Collectively, the Radiant and Impact sites will add around 80 new subjects
» to the study. Combined with at least twenty new additions at a site hosted
» by TKL Research, the second phase of ARI’s clinical study will surpass 200
» subjects in total, a remarkable number of participants for a Phase 2 trial.

Yes, that’s really an “remarkable number of participants for a Phase 2 trial” …
… especially for cell-based products … :smiley:

Thanks to god, that Aderans do not research urinary bladders organs!!
(Try to find 200 urinary bladder trail participants for cell-based urinary bladder products - they could never finish their trails)

Funny …


#8

So, it seems that there is nothing that suggests a combined PhaseII+III (Iron_Man’s hypothesis).
It is funny how Iron_Man presents hypothesis, but he presents them as facts, and fiercely attacks whoever dares to contradict or doubt him.

Now Iron_Man is very worried about the precise starting date of the Phase II trial. But regarding to Gho, he is never worried about anything.:smiley:

» Thanks to @Dogster who found this new Aderans press release and
» posted it - IMHO a little bit too hidden - in another (related) topic …
»
» -----------------------
» Source: http://www.prweb.com/releases/hair/regeneration/prweb3954514.htm
»
» Aderans Research Expands Clinical Studies
»
» Aderans Research Institute Inc. (ARI) said today it has expanded its
» clinical trials on hair regeneration by an additional seven cities in the
» United States.
»
» Atlanta, GA (PRWEB) May 4, 2010 – Aderans Research Institute Inc.
» (ARI) said today it has expanded its clinical trials on hair regeneration
» by an additional seven cities in the United States. Las Vegas, NV; Los
» Angeles, CA; and New Hyde Park, NY, have been added through clinical site
» company Impact Clinical Trials. Tucson, AZ; St. Louis, MO; Birmingham, AL;
» and St. Petersburg, FL, have been added through clinical site company
» Radiant Research.
»
» Collectively, the Radiant and Impact sites will add around 80 new subjects
» to the study. Combined with at least twenty new additions at a site hosted
» by TKL Research, the second phase of ARI’s clinical study will surpass 200
» subjects in total, a remarkable number of participants for a Phase 2 trial.
»
»
» “The expansion of our study reflects not only the significance of the
» investment made by Aderans Co. Ltd of Japan, but also our confidence that
» we’re getting closer to a commercial viable solution to the problems of
» hair loss,” said Vern Liebmann, Vice President, Operations.
»
» Added ARI Executive Vice President Ken Washenik M.D., Ph.D., “We’ve
» received some encouraging results from our initial Phase 2 studies and
» we’re eager to expand the trial, add new protocols, and refine our
» knowledge of the hair multiplication and regeneration process.”
»
» Kurt Stenn M.D., Vice President of Research and Chief Scientific Officer,
» commented, “It is gratifying to see our research being steadily confirmed
» in our clinical work.”
»
» Phase 2 launched in November of 2008. Phase 1 of ARI’s
» clinical study began in September of 2006 and concluded in February of
» 2008.

»
» About Aderans Research
»
» Aderans Research is a pioneer in the research and development of safe,
» effective cell engineered products for hair regeneration. With offices in
» Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of
» Aderans Company, Ltd., the world’s largest wig manufacturer, and an
» affiliate of Bosley, a global leader in medical hair restoration.
»
» More information on ARI’s study outcomes will be released as studies
» unfold. To see ARI’s latest clinical updates, please visit
» http://www.aderansresearch.com/ari_clinicupdates.html
»
» Additional information on ARI can be found at www.aderansresearch.com.
»
» Learn more about Aderans Co., Ltd. At http://www.aderans.co.jp/e/company/
»
» ###
» --------------------------------
»
» By the way …
» ------------
» Phase 2 launched in November of 2008. Phase 1 of ARI’s
» clinical study began in September of 2006 and concluded in February of
» 2008.

» ------------
»
» This is the reason, why I often mention “Do not believe in every press
» release …!”

»
» Phase 2 launched - as most of you guys know - in April
» 2009
!


#9

» So, it seems that there is nothing that suggests a combined PhaseII+III
» (Iron_Man’s hypothesis).
» It is funny how Iron_Man presents hypothesis, but he presents them as
» facts, and fiercely attacks whoever dares to contradict or doubt him.
»
» Now Iron_Man is very worried about the precise starting date of the Phase
» II trial. But regarding to Gho, he is never worried about anything.:smiley:

Training, about which CRAP do you talk??
Can’t you read the FACTS (different declarations by Aderans in different press releases) posts above??


#10

I wouldn’t mind if they took until 2011 with phase #2. I just wanna hear that it actually WORKS when the smoke clears.


#11

» I wouldn’t mind if they took until 2011 with phase #2. I just wanna hear
» that it actually WORKS when the smoke clears.

Couldnt have said it better myself. I want somethin now but if i was told in 5 years its gonna be a certainty i’d be ecstatic with that.


#12

» » I wouldn’t mind if they took until 2011 with phase #2. I just wanna
» hear
» » that it actually WORKS when the smoke clears.
»
» Couldnt have said it better myself. I want somethin now but if i was told
» in 5 years its gonna be a certainty i’d be ecstatic with that.

TRUE! I actually think that makes 100% sense, in the mean time I should practice patience.


#13

» So, it seems that there is nothing that suggests a combined PhaseII+III
» (Iron_Man’s hypothesis).

Under what circumstances will they consider a combined phase II and III trial??


#14

» » So, it seems that there is nothing that suggests a combined PhaseII+III
» » (Iron_Man’s hypothesis).
»
»
» Under what circumstances will they consider a combined phase II and III
» trial??

it makes no sense to consider a II+III trial, once phaseII has been completed.


#15

I agree with Cal on this one. Keep in mind that all of the Aderans representatives cited in this press release indicated that the process DOES work to some extent. They specifically said that this move represents confidence in their early results.

The extension of Phase 2 COULD be a bad thing, but Phase 3 is so expensive that I’ll bet they want to get every kink figured out before they move forward. We just need to hope that they CAN figure out the kinks.


#16

» I agree with Cal on this one. Keep in mind that all of the Aderans
» representatives cited in this press release indicated that the process DOES
» work to some extent. They specifically said that this move represents
» confidence in their early results.
»
» The extension of Phase 2 COULD be a bad thing, but Phase 3 is so expensive
» that I’ll bet they want to get every kink figured out before they move
» forward. We just need to hope that they CAN figure out the kinks.

Is your kink-story

  • just a hypothesis or
  • just a claim or
  • just a assumption or
  • just a speculation ?

Or COULD it simply be just CRAP?


#17

» » I agree with Cal on this one. Keep in mind that all of the Aderans
» » representatives cited in this press release indicated that the process
» DOES
» » work to some extent. They specifically said that this move represents
» » confidence in their early results.
» »
» » The extension of Phase 2 COULD be a bad thing, but Phase 3 is so
» expensive
» » that I’ll bet they want to get every kink figured out before they move
» » forward. We just need to hope that they CAN figure out the kinks.
»
» Is your kink-story
»
» - just a hypothesis or
» - just a claim or
» - just a assumption or
» - just a speculation ?
»
» Or COULD it simply be just CRAP?

His kink story is plausible. Either way, this is excellent news. Now we just have to wait and see what results from the trials.


#18

» Is your kink-story
» - just a hypothesis or
» - just a claim or
» - just a assumption or
» - just a speculation ?
» Or COULD it simply be just CRAP?

Shooter’s response was perfectly logical. Yours was full of contempt.


#19

» » They didn’t lie. Phase 2 starts at recruitment. They started recruiting
» » during 2008.
»
» And what can you read in THIS press release???
» ----------------
» http://www.prweb.com/releases/pattern_hair_loss_study/hair_restoration_research/prweb2358404.htm
»
»
» Atlanta, GA (PRWEB) April 27, 2009 – Aderans Research Institute
» Inc. (ARI) announced today it has launched Phase 2 of its clinical
» study
on cell-based hair regeneration for men and women. Structured
» around the findings of the recently completed Phase 1 of the study,
» this second phase will continue to evaluate the impact of its novel cell
» treatment process on pattern hair loss, also known as androgenetic
» alopecia.
» ------------------

did you read shooters post? it makes perfect sense


#20

» » I agree with Cal on this one. Keep in mind that all of the Aderans
» » representatives cited in this press release indicated that the process
» DOES
» » work to some extent. They specifically said that this move represents
» » confidence in their early results.
» »
» » The extension of Phase 2 COULD be a bad thing, but Phase 3 is so
» expensive
» » that I’ll bet they want to get every kink figured out before they move
» » forward. We just need to hope that they CAN figure out the kinks.
»
» Is your kink-story
»
» - just a hypothesis or
» - just a claim or
» - just a assumption or
» - just a speculation ?
»
» Or COULD it simply be just CRAP?

he clearly said he “bets” that is the reason, stating that it is based on pure assumption not fact… he is free to speak his mind… why do you have to pounce on everyone who disagrees with you?